After a year and a half of big names pushing the market forward, some smaller companies are starting to go on a run.
/CVS%20Health%20Corp%20location-by%20jetcityimage%20via%20iStock.jpg)
CVS Health is all set to announce its second-quarter results next month, and analysts are projecting a double-digit decline in the company’s bottom-line figure.
Find out if the huge yields these pressured dividend payers offer could be worth the risk.
The big pharma company's top drug is losing ground, but its dividend keeps rising.
New York, New York--(Newsfile Corp. - July 17, 2024) - If you suffered a loss on your CVS Health Corporation (NYSE: CVS) investment and want to learn about a potential recovery under the federal securities...
There's an argument to be made that investors should cut their losses and leave, but there is more to the story.
Are investors being overly bearish on CVS Health?
After falling a long way, the pharmacy stock is trading at a surprisingly low valuation.
/CVS%20Health%20Corp%20corporate%20office-by%20JHVEPhoto%20via%20iStock.jpg)
CVS Health has recently lagged the Dow Jones Industrial Average, but analysts are optimistic about the stock’s prospects.
Their prices might not be done falling, but you can count on the dividends they distribute to continue rising steadily.